These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1812375)

  • 21. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
    Zhang RX; Dougherty DV; Rosenblum ML
    Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 2: Dose-effect relationships and 31P NMR spectroscopy of L 1210 cells (monolayers) and 9L glioma cells (monolayers and tumor spheroids) treated with activated isophosphamide, adriamycin, epirubicin and 6 MeV electrons.
    Ulmer W
    Strahlenther Onkol; 1991 Aug; 167(8):484-93. PubMed ID: 1887366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 31P-NMR investigation of solid tumours in the living rat.
    Griffiths JR; Stevens AN; Iles RA; Gordon RE; Shaw D
    Biosci Rep; 1981 Apr; 1(4):319-25. PubMed ID: 7295895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular pH measurements by 31P nuclear magnetic resonance. Influence of factors other than pH on 31P chemical shifts.
    Roberts JK; Wade-Jardetzky N; Jardetzky O
    Biochemistry; 1981 Sep; 20(19):5389-94. PubMed ID: 7295683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reaction of the isosteric methylenephosphonate analog of alpha-D-glucose 1-phosphate with phosphoglucomutase. Induced-fit specificity revisited.
    Ray WJ; Post CB; Puvathingal JM
    Biochemistry; 1993 Jan; 32(1):38-47. PubMed ID: 8418857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentials and limitations of a clonogenic cell assay for human brain tumors.
    Rosenblum ML; Dougherty DV; Deen DF; Wilson CB
    Cancer Treat Rep; 1981; 65 Suppl 2():61-6. PubMed ID: 7346148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA alkylation products formed by 1-(2-chloroethyl)-1-nitrosourea as molecular dosimeters of therapeutic response.
    Bodell WJ
    J Neurooncol; 2009 Feb; 91(3):257-64. PubMed ID: 18979209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 31P and 1H NMR spectroscopy of tumors in vivo: untreated growth and response to chemotherapy.
    Wehrle JP; Li SJ; Rajan SS; Steen RG; Glickson JD
    Ann N Y Acad Sci; 1987; 508():200-15. PubMed ID: 3439701
    [No Abstract]   [Full Text] [Related]  

  • 29. Excision repair cross-complementing rodent repair deficiency gene 2 expression and chloroethylnitrosourea resistance in human glioma cell lines.
    Chen ZP; McQuillan A; Mohr G; Panasci LC
    Neurosurgery; 1998 May; 42(5):1112-9. PubMed ID: 9588557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor.
    Pollack IF; Kawecki S; Lazo JS
    J Neurosurg; 1996 Jun; 84(6):1024-32. PubMed ID: 8847567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variations in response of human brain tumors to BCNU in vitro.
    Kornblith PL; Szypko PE
    J Neurosurg; 1978 Apr; 48(4):580-6. PubMed ID: 632883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hypoglycaemia and hypoxia on the intracellular pH of cerebral tissue as measured by 31P nuclear magnetic resonance.
    Brooks KJ; Porteous R; Bachelard HS
    J Neurochem; 1989 Feb; 52(2):604-10. PubMed ID: 2911032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pentose phosphate pathway alterations in multi-drug resistant leukemic T-cells: 31P NMR and enzymatic studies.
    Ferretti A; Chen LL; Di Vito M; Barca S; Tombesi M; Cianfriglia M; Bozzi A; Strom R; Podo F
    Anticancer Res; 1993; 13(4):867-72. PubMed ID: 8102518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental study of combination therapy against human glioma xenograft by differentiation-inducing agent and cytotoxic chemotherapeutic drug].
    Shi MG; Huang Q; Dong J; Sun ZF; Lan Q
    Ai Zheng; 2002 Oct; 21(10):1090-4. PubMed ID: 12508650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
    Kapp J; Vance R; Parker JL; Smith RR
    Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
    [No Abstract]   [Full Text] [Related]  

  • 37. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.
    Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L
    Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
    Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
    J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of phosphorylase in total global ischaemia in the rat heart. A phosphorus-31 nuclear-magnetic-resonance study.
    Bailey IA; Williams SR; Radda GK; Gadian DG
    Biochem J; 1981 Apr; 196(1):171-8. PubMed ID: 7306067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.
    Safdari H; Mompeon B; Dubois JB; Gros C
    Surg Neurol; 1985 Nov; 24(5):490-7. PubMed ID: 4049223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.